Clinical Trial Update: Melatonin Versus Placebo in Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial compared melatonin to placebo in breast cancer patients to assess safety and early efficacy signals. Results were posted in February 2015…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2015-02-23